ANDHealth is set to take one of its largest-ever delegations of Australian digital and connected health companies to the United States this November, connecting local innovators with customers, investors, strategic partners and global healthcare leaders across Silicon Valley, San Francisco and Las Vegas.
Running from 10-18 November 2026, the delegation will combine a tailored US market-access program with participation at HLTH US, the major healthcare innovation event that brings together more than 12,000 leaders, investors, insurers and health technology companies.
Delegates will receive one-on-one market-entry support, expert workshops on areas including reimbursement, regulation and capital raising, curated business meetings and access to ANDHealth’s established network of US investors, service providers and venture partners.
The program will include activity across the Silicon Valley and San Francisco – with engagements already locked in with organisations such as Amazon Health, Anthropic, Fogarty Innovation, UCSF Innovation Ventures and leading investors – including American Heart Association, Rock Health, McKesson Ventures, Aphelion Capital and Laerdal Million Lives Fund.
ANDHealth CEO Bronwyn Le Grice said the size of the delegation reflected growing momentum among Australian digital and connected health companies seeking to scale and commercialise internationally.
“Australia is home to a significant pipeline of world-class digital and connected health technologies and innovators, and the US represents a significant opportunity for those ready to scale. This delegation gives participants practical market intelligence, trusted introductions and the on-the-ground support needed to translate their cutting-edge innovations into meaningful impact at scale,” Ms Le Grice said.
“Two months out from our US delegation we’ve already had 13 companies confirm their participation, with a number of others expressing interest, so I’d encourage companies to register now secure their spot.
“The companies already registered represent a range of maturity, from those exploring whether the US is the right market for them, to those already operating in-market and seeking opportunities to further scale.”
ANDHealth has supported more than 240 participants through its delegations since 2019. Its 2026 UK & EU delegation and 2025 US delegation both achieved outstanding Net Promoter Scores of 100, with all participants reporting they made valuable business connections through the program.
Companies interested in joining the 2026 US Delegation or taking a company kiosk at Australia’s national pavilion at HLTH US are encouraged to contact ANDHealth’s Tayla Turner.
For those unable to attend the delegation, ANDHealth is also running an exclusive three-part webinar series ‘Supercharge your US expansion’ featuring real-world advice from US investors and market access experts, on 1, 9 and 21 October 2026.
More information, including how to submit an EOI to join the delegation is available here.
Add Comment